Try our mobile app

Switch to company model in classical logic    *

General information

Country: UNITED STATES

Sector: Mortgage Finance

Hercules Capital, Inc. is a business development company. The firm specializing in providing venture debt, debt, senior secured loans, and growth capital to privately held venture capital-backed companies at all stages of development from startups, to expansion stage including select publicly listed companies and select special opportunity lower middle market companies that require additional capital to fund acquisitions, recapitalizations and refinancing and established-stage companies. The firm provides growth capital financing solutions for capital extension; management buy-out and corporate spin-out financing solutions; company, asset specific, or intellectual property acquisition financing; convertible, subordinated and/or mezzanine loans; domestic and international corporate expansion; vendor financing; revenue acceleration by sales and marketing development, and manufacturing expansion. It provides asset-based financing with a focus on cash flow; accounts receivable facilities; equipment loans or leases; equipment acquisition; facilities build-out and/or expansion; working capital revolving lines of credit; inventory. The firm also provides bridge financing to IPO or mergers and acquisitions or technology acquisition; dividend recapitalizations and other sources of investor liquidity; cash flow financing to protect against share price volatility; competitor acquisition; ...
Website: htgc.com



Growth: Bad revenue growth rate -91.2%, there is slowdown compared to average historical growth rates 24.3%. The revenue growth dynamics is unstable

Profitability: LTM net profit margin is positive, +62.4%. On average the margin is decreasing unsteadily. Gross margin is low, 0.0%. In the last quarter the company beat the estimated EPS, +4.3%. The company was ahead of estimated EPS in 60% of quarters (showing a gain of +$0.02 per share on average)

Cash Flow Generation: Dividend yield for the last twelve months 9.9%.

Undervaluation: Fundamental value created in LTM (estimate)


Entry Point: Share price is 68.6% higher than minimum and 0.0% lower than maximum for the last 3 years

AI Insight: the companies with similar growth trajectories, Net Income margin, industries and geography on average are valued 4.1x by P / Sales multiple , the company can be 82.8% overvalued

Key Financials (Download financials)

Ticker: HTGC
Share price, USD:  (+0.9%)19.3
year average price 16.41  


year start price 12.54 2023-05-04

min close price 12.54 2023-05-04

max close price 19.30 2024-05-01

current price 19.30 2024-05-02
Common stocks: 123 878 993

Dividend Yield:  9.9%
P / E LTM: 38.0x
P / E annualized: 298.9x
Last revenue growth (y/y):  -91.2%
Last growth of Net Income (y/y):  -97.6%
Historical revenue growth:  24.3%
Historical growth of Net Income:  18.6%
P / Sales: 23.7x
Margin (Net Income LTM / Revenue): 62.4%
Fundamental value created in LTM:
Market Cap ($m): 2 391
Price to Book: 1.3x

Revenue and Net Income

Quarterly values ($m)

Change (y/y)

Share price and dividends (Download history)

Share price

Payment USD per share

Multiple and potential

EV / Sales

Potential dynamics

News


2024-04-27The Motley Fool

Is Hercules Capital Stock a Buy?

2024-04-26Zacks Investment Research

Hercules Capital (HTGC) Rises Yet Lags Behind Market: Some Facts Worth Knowing

2024-04-20The Motley Fool

Better High-Yield Buy: Hercules Capital or PennantPark?

2024-04-17Zacks Investment Research

All You Need to Know About Hercules Capital (HTGC) Rating Upgrade to Buy

2024-04-16The Motley Fool

Billionaires Are Buying These 2 Ultra-High Yield Dividend Stocks Hand Over Fist. Are They Smart Buys for Your Portfolio?

2024-03-30Seeking Alpha

Hercules Capital: Trades At A Premium For A Reason (Rating Upgrade)

2024-03-29Seeking Alpha

Hercules Capital: Record Year In 2023, 10% Yield

2024-03-15Zacks Investment Research

Hercules Capital (HTGC) Advances While Market Declines: Some Information for Investors

2024-02-28Seeking Alpha

Hercules Capital Q4: Quality Does Have Its Price

2024-02-23Seeking Alpha

Unlocking Hercules Capital's Income Potential: A Fresh Look At Dividend Timing Strategies
More information for subscribed users:
detailed calculation of
Fundamental value created in LTM

Financial reporting

Income Statement

Property 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3
date 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30
symbol HTGC HTGC HTGC HTGC HTGC HTGC
reportedCurrency USD USD USD USD USD USD
cik 1M 1M 1M 1M 1M 1M
fillingDate 2024-02-15 2023-09-30 2023-08-03 2023-03-31 2023-02-16 2022-11-02
acceptedDate 2024-02-15 16:17:43 2023-09-29 20:00:00 2023-08-03 16:18:26 2023-03-31 00:00:00 2023-02-16 16:08:16 2022-11-02 16:08:49
calendarYear 2023.000 2023.000 2023.000 2023.000 2022.000 2022.000
period Q4 Q3 Q2 Q1 Q4 Q3
revenue 139M 51M 118M 118M 85M 73M
costOfRevenue 37M 3M 13M 0 33M 11M
grossProfit 102M 49M 105M 118M 52M 62M
grossProfitRatio 0.731 0.950 0.891 1.000 0.612 0.850
researchAndDevelopmentExpenses 0 0 0 0 0 0
generalAndAdministrativeExpenses 5M 5M 5M 4M 4M 4M
sellingAndMarketingExpenses 0 0 0 0 0 0
sellingGeneralAndAdministrativeExpenses 5M 5M 5M 4M 4M 4M
otherExpenses 34M -67M 25M 19M 18M 15M
operatingExpenses 19M 24M 23M 23M 22M 20M
costAndExpenses 76M 24M 43M 23M 106M 36M
interestIncome 115M 110M 109M 100M 95M 81M
interestExpense 17M 16M 17M 17M 16M 14M
depreciationAndAmortization 23 000 59 000 64 000 44 000 44 000 50 000
ebitda -284M 28M 66M 111M 150M 137M
ebitdaratio -2.040 0.544 0.559 0.946 1.767 1.879
operatingIncome 63M 28M 66M 111M 150M 137M
operatingIncomeRatio 0.456 0.543 0.559 0.946 1.767 1.878
totalOtherIncomeExpensesNet -281M -16M 29M -17M -87M -84M
incomeBeforeTax 120M 28M 95M 95M 63M 53M
incomeBeforeTaxRatio 0.862 0.543 0.802 0.805 0.739 0.729
incomeTaxExpense -17M -16M -64 000 17M -16M -14M
netIncome 120M 28M 95M 95M 63M 53M
netIncomeRatio 0.862 0.543 0.802 0.805 0.739 0.729
eps 0.760 0.190 0.660 0.690 0.480 0.410
epsdiluted 0.760 0.190 0.660 0.680 0.470 0.410
weightedAverageShsOut 158M 147M 141M 135M 131M 127M
weightedAverageShsOutDil 158M 147M 142M 137M 132M 129M
link Link Link Link Link
finalLink Link Link Link Link

Balance Sheet Statement

Property 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3
date 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30
symbol HTGC HTGC HTGC HTGC HTGC HTGC
reportedCurrency USD USD USD USD USD USD
cik 1M 1M 1M 1M 1M 1M
fillingDate 2024-02-15 2023-09-30 2023-08-03 2023-03-31 2023-02-16 2022-11-02
acceptedDate 2024-02-15 16:17:43 2023-09-29 20:00:00 2023-08-03 16:18:26 2023-03-31 00:00:00 2023-02-16 16:08:16 2022-11-02 16:08:49
calendarYear 2023.000 2023.000 2023.000 2023.000 2022.000 2022.000
period Q4 Q3 Q2 Q1 Q4 Q3
cashAndCashEquivalents 99M 32M 62M 71M 16M 57M
shortTermInvestments 0 0 0 0 2 887M 2 745M
cashAndShortTermInvestments 99M 32M 62M 71M 2 903M 2 802M
netReceivables 33M 32M 32M 31M 32M 25M
inventory 149M 1.000 0 0 0 0
otherCurrentAssets -149M -69M 0 0 0 0
totalCurrentAssets 132M 64M 94M 103M 2 935M 2 828M
propertyPlantEquipmentNet 5M 5M 4M 4M 5M 6M
goodwill 0 0 0 0 0 0
intangibleAssets 0 0 0 0 0 0
goodwillAndIntangibleAssets 0 0 0 0 0 0
longTermInvestments 3 248M 3 261M 3 113M 3 130M 2 964M 2 826M
taxAssets 0 0 0 0 0 0
otherNonCurrentAssets -3 248M -3 266M -3 113M -3 135M -2 964M -2 826M
totalNonCurrentAssets 5M 3 266M 4M 3 135M 5M 6M
otherAssets 3 280M 6M 3 127M 15M 89M 91M
totalAssets 3 417M 3 336M 3 225M 3 252M 3 029M 2 925M
accountPayables 54M 46M 47M 33M 48M 34M
shortTermDebt 5M 367 000 4M 0 6M 6M
taxPayables 0 0 0 0 0 0
deferredRevenue 0 46M 0 0 0 0
otherCurrentLiabilities -54M -46M -47M -33M -48M -34M
totalCurrentLiabilities 5M 46M 4M 33M 6M 6M
longTermDebt 1 560M 1 638M 1 592M 1 719M 1 580M 1 527M
deferredRevenueNonCurrent 0 0 0 0 0 0
deferredTaxLiabilitiesNonCurrent 0 0 0 0 0 0
otherNonCurrentLiabilities 49M -1 638M 43M -1 686M 42M 1 515M
totalNonCurrentLiabilities 1 609M 1 638M 1 635M 33M 1 622M 1 556M
otherLiabilities 0 0 0 1 686M 0 0
capitalLeaseObligations 5M 5M 4M 0 6M 6M
totalLiabilities 1 614M 1 684M 1 639M 1 753M 1 627M 1 562M
preferredStock 0 0 0 0 0 0
commonStock 158 000 152 000 145 000 139 000 134 000 131 000
retainedEarnings 140M 73M 117M 90M 60M 74M
accumulatedOtherComprehensiveIncomeLoss 6M 0.000 0 0 0 0
othertotalStockholdersEquity 1 656M 1 579M 1 468M 1 409M 1 341M 1 288M
totalStockholdersEquity 1 803M 1 652M 1 586M 1 499M 1 401M 1 363M
totalEquity 1 803M 1 652M 1 586M 1 499M 1 401M 1 363M
totalLiabilitiesAndStockholdersEquity 3 417M 3 336M 3 225M 3 252M 3 029M 2 925M
minorityInterest 0 0 0 0 0 0
totalLiabilitiesAndTotalEquity 3 417M 3 336M 3 225M 3 252M 3 029M 2 925M
totalInvestments 3 248M 3 261M 3 113M 3 130M 2 964M 2 826M
totalDebt 1 560M 1 638M 1 592M 1 719M 1 580M 1 527M
netDebt 1 461M 1 606M 1 531M 1 648M 1 564M 1 470M
link Link Link Link Link
finalLink Link Link Link Link

Cash Flow Statement

Property 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3
date 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30
symbol HTGC HTGC HTGC HTGC HTGC HTGC
reportedCurrency USD USD USD USD USD USD
cik 1M 1M 1M 1M 1M 1M
fillingDate 2024-02-15 2023-09-30 2023-08-03 2023-03-31 2023-02-16 2022-11-02
acceptedDate 2024-02-15 16:17:43 2023-09-29 20:00:00 2023-08-03 16:18:26 2023-03-31 00:00:00 2023-02-16 16:08:16 2022-11-02 16:08:49
calendarYear 2023.000 2023.000 2023.000 2023.000 2022.000 2022.000
period Q4 Q3 Q2 Q1 Q4 Q3
netIncome 120M 28M 95M 95M 63M 53M
depreciationAndAmortization 23 000 59 000 64 000 44 000 44 000 50 000
deferredIncomeTax -27M -3M 0 0 0 0
stockBasedCompensation 3M 3M 0 0 2M 8M
changeInWorkingCapital -22M 169 000 15M -11M 8M -7M
accountsReceivables -684 000 27 000 0 0 0 0
inventory 0 0 0 0 0 0
accountsPayables 0 0 0 0 0 0
otherWorkingCapital -21M 142 000 0 0 0 0
otherNonCashItems 48M -144M 23M -165M -138M -108M
netCashProvidedByOperatingActivities 131M -115M 134M -81M -65M -53M
investmentsInPropertyPlantAndEquipment -497 000 -11 000 -285 000 -94 000 -28 000 -12 000
acquisitionsNet 887 000 0 0 0 0 0
purchasesOfInvestments -1 599M -457M 0 0 -367M -1 098M
salesMaturitiesOfInvestments 1 046M 268M 0 0 153M 392M
otherInvestingActivites 552M 189M 0 0 214M 705M
netCashUsedForInvestingActivites -497 000 -11 000 -285 000 -94 000 -28 000 -12 000
debtRepayment -205M -110M -282M -86M -53M -24M
commonStockIssued 101M 111M 66M 66M 40M 43M
commonStockRepurchased -577 000 -512 000 -10M -1M 206 000 -572 000
dividendsPaid -72M -71M -66M -64M -66M -63M
otherFinancingActivites 125M 149M 154M 219M 104M 44M
netCashUsedProvidedByFinancingActivities -52M 79M -138M 134M 25M -83 000
effectOfForexChangesOnCash 0 0 0 0 0 0
netChangeInCash 79M -37M -5M 53M -40M -53M
cashAtEndOfPeriod 116M 37M 74M 79M 26M 65M
cashAtBeginningOfPeriod 37M 74M 79M 26M 65M 119M
operatingCashFlow 131M -115M 134M -81M -65M -53M
capitalExpenditure -497 000 -11 000 -285 000 -94 000 -28 000 -12 000
freeCashFlow 130M -115M 133M -81M -65M -53M
link Link Link Link Link
finalLink Link Link Link Link

Earning call transcript

2023 q4
2024-02-15 ET (fiscal 2023 q4)
2023 q3
2023-11-02 ET (fiscal 2023 q3)
2023 q2
2023-08-03 ET (fiscal 2023 q2)
2023 q1
2023-05-04 ET (fiscal 2023 q1)
2022 q4
2023-02-16 ET (fiscal 2022 q4)
2022 q3
2022-11-02 ET (fiscal 2022 q3)
2022 q2
2022-07-28 ET (fiscal 2022 q2)
2022 q1
2022-05-05 ET (fiscal 2022 q1)

Press-releases

Show financial reports only

2024-04-30 10:00 ET
Hercules Capital Declares a Total Cash Distribution of $0.48 per Share for the First Quarter 2024
2024-04-30 07:00 ET
SynOx Therapeutics secures up to $35m debt financing with Hercules Capital to progress development and commercialisation of emactuzumab
2024-04-24 10:00 ET
Hercules Capital Celebrates 20th Anniversary with $20.0 Billion in Cumulative Originations
2024-04-18 10:00 ET
Hercules Capital Announces Date for Release of First Quarter 2024 Financial Results and Conference Call
2024-03-27 10:00 ET
Hercules Capital Receives BBB- Affirmed Investment Grade Credit and Corporate Rating from Fitch Ratings, Inc.
2024-03-21 10:00 ET
Hercules Capital Receives Confirmed BBB Investment Grade Rating with Revised Outlook to Positive from Morningstar DBRS
2024-02-20 11:00 ET
Hercules Capital Announces Upcoming Event for the Financial Community
2024-02-15 21:07 ET
Hercules Capital Reports Fourth Quarter and Full-Year 2023 Financial Results
2024-02-13 11:02 ET
Hercules Capital Declares a Total Cash Distribution of $0.48 per Share for the Fourth Quarter 2023
2024-02-13 11:00 ET
Hercules Capital Announces New Supplemental Cash Distribution of $0.32 per Share
2024-01-25 11:00 ET
Hercules Capital Announces Date for Release of Fourth Quarter and Full-Year 2023 Financial Results and Conference Call
2024-01-02 07:00 ET
Verona Pharma enters into Debt Facility of up to $400 Million with Oxford Finance and Hercules Capital
2023-12-22 22:00 ET
enGene Announces Expanded $50 Million Debt Facility with Hercules Capital
2023-12-14 13:00 ET
Phathom Pharmaceuticals Announces Expansion of Existing Loan and Security Agreement with Hercules Capital
2023-11-09 21:10 ET
Hercules Capital Receives SBA “Green Light” Letter to Submit Its Fourth SBIC License Application
2023-11-08 11:00 ET
Hercules Capital Announces Upcoming Events for the Financial Community
2023-11-02 20:10 ET
Hercules Capital Reports Third Quarter 2023 Financial Results
2023-10-31 10:00 ET
Hercules Capital Declares a Total Cash Distribution of $0.48 per Share for the Third Quarter 2023
2023-10-12 10:00 ET
Hercules Capital Announces Date for Release of Third Quarter 2023 Financial Results and Conference Call
2023-10-04 10:00 ET
Hercules Capital Receives Reaffirmed Baa3 Investment Grade Credit and Corporate Rating from Moody’s Investors Service
2023-09-25 10:00 ET
Hercules Capital Announces the Appointment of Mr. Nikos Theodosopoulos to Its Board of Directors
2023-08-31 10:00 ET
Hercules Receives a BBB+ Reaffirmed Investment Grade Corporate Rating from Kroll Bond Rating Agency, Inc.
2023-08-08 00:42 ET
Hercules Capital, Inc. Prices Upsized Public Offering of Common Stock
2023-08-07 20:17 ET
Hercules Capital, Inc. Announces Public Offering of Common Stock
2023-08-03 20:10 ET
Hercules Capital Reports Second Quarter 2023 Financial Results
2023-08-03 12:00 ET
X4 Pharmaceuticals Closes $115 Million Loan Facility with Hercules Capital
2023-08-01 10:00 ET
Hercules Capital Increases Its Total Cash Distribution to $0.48 per Share for the Second Quarter 2023
2023-07-10 10:00 ET
Hercules Capital Announces Date for Release of Second Quarter 2023 Financial Results and Conference Call
2023-05-15 15:00 ET
Tipalti Secures $150 Million in Growth Financing from JPMorgan Chase Bank and Hercules Capital
2023-05-11 10:00 ET
Hercules Capital Announces Date of 2023 Annual Meeting of Stockholders
2023-05-04 20:10 ET
Hercules Capital Reports First Quarter 2023 Financial Results
2023-05-02 10:00 ET
Hercules Capital Declares a Total Cash Distribution of $0.47 per Share for the First Quarter 2023
2023-04-20 10:00 ET
Hercules Capital Announces Date for Release of First Quarter 2023 Financial Results and Conference Call
2023-04-04 10:00 ET
Hercules Capital Receives BBB- Reaffirmed Investment Grade Credit and Corporate Rating from Fitch Ratings, Inc.
2023-03-27 10:00 ET
Hercules Adviser LLC Establishes A New Institutional Private Credit Lending Program
2023-03-22 10:00 ET
Hercules Capital Increases Its Committed Letter of Credit Facility with SMBC
2023-03-14 14:02 ET
EPAM Welcomes DeAnne Aguirre to its Board of Directors
2023-03-14 12:05 ET
Gibraltar Business Capital Launches Gibraltar Equipment Finance
2023-03-13 10:00 ET
Hercules Capital Business Update and Response to the Closure of Silicon Valley Bank
2023-02-24 11:00 ET
Hercules Capital Announces Upcoming Event for the Financial Community
2023-02-16 21:10 ET
Hercules Capital Reports Fourth Quarter and Full-Year 2022 Financial Results
2023-02-14 11:03 ET
Hercules Capital Announces New Supplemental Cash Distribution of $0.32 per Share
2023-02-14 11:00 ET
Hercules Capital Increases Its Quarterly Cash Distribution to $0.39 per Share for the Fourth Quarter of 2022
2023-02-02 21:01 ET
Provention Bio Announces Closing of Second Tranche with Hercules Capital to Support U.S. Commercial Launch of TZIELD®
2023-02-02 11:00 ET
Hercules Capital Announces Date for Release of Fourth Quarter and Full-Year 2022 Financial Results and Conference Call
2022-12-07 11:00 ET
Hercules Capital Announces Upcoming Event for the Financial Community
2022-11-16 11:00 ET
Hercules Capital Announces Upcoming Events for the Financial Community
2022-11-02 20:05 ET
Hercules Capital Reports Third Quarter 2022 Financial Results
2022-10-19 20:05 ET
Tricida Announces $125 Million Debt Facility with Hercules Capital
2022-10-19 10:00 ET
Hercules Capital Announces Date for Release of Third Quarter 2022 Financial Results and Conference Call
2022-10-18 10:03 ET
Hercules Capital Announces Supplemental Cash Distribution of $0.15 per Share for the Third Quarter of 2022
2022-10-18 10:00 ET
Hercules Capital Increases Its Quarterly Cash Distribution to $0.36 per Share for the Third Quarter of 2022
2022-10-07 12:00 ET
Replimune Secures $200 Million in Non-Dilutive Debt Financing from Hercules Capital, Inc.
2022-10-03 13:00 ET
Automation Anywhere Secures $200 Million in Financing from Silicon Valley Bank and Hercules Capital
2022-09-13 10:00 ET
Hercules Receives a BBB+ Reaffirmed Investment Grade Corporate Rating from Kroll Bond Rating Agency, Inc.
2022-08-31 22:12 ET
Provention Bio Announces $125 Million Term Loan Facility with Hercules Capital
2022-08-30 11:00 ET
Alladapt Announces Loan Agreement with Hercules Capital
2022-07-28 20:10 ET
Hercules Capital Reports Second Quarter 2022 Financial Results
2022-07-26 10:03 ET
Hercules Capital Announces Supplemental Cash Distribution of $0.15 per Share for the Second Quarter of 2022
2022-07-26 10:00 ET
Hercules Capital Increases Its Quarterly Cash Distribution to $0.35 per Share for the Second Quarter of 2022
2022-07-14 10:00 ET
Hercules Capital Announces Date for Release of Second Quarter 2022 Financial Results and Conference Call
2022-06-30 20:15 ET
Geron Corporation Announces Expansion of Existing Loan Facility
2022-06-24 10:00 ET
Hercules Capital Announces the Appointment of Ms. DeAnne Aguirre to Its Board of Directors
2022-06-23 20:10 ET
Hercules Capital Completes Two Institutional Debt Financings, Raising a Total of $200.0 Million to Support Continued Growth
2022-06-16 11:00 ET
Akero Therapeutics Announces Two Financing Transactions with Pfizer Inc. and Hercules Capital, Inc. Providing Access to Up To $125 Million
2022-06-15 10:00 ET
Hercules Capital Expands Its Credit Facilities to $720 Million to Support Strong Investment Portfolio Growth
2022-05-10 10:00 ET
Hercules Capital Receives BBB- Investment Grade Credit and Corporate Rating from Fitch Ratings, Inc.
2022-05-09 10:00 ET
Hercules Capital Announces Date of 2022 Annual Meeting of Stockholders
2022-05-05 20:10 ET
Hercules Capital Reports First Quarter 2022 Financial Results
2022-05-03 10:03 ET
Hercules Capital Announces Supplemental Cash Distribution of $0.15 per Share for the First Quarter of 2022
2022-05-03 10:00 ET
Hercules Capital Declares Cash Distribution of $0.33 per Share for the First Quarter of 2022
2022-04-18 10:00 ET
Hercules Receives a BBB Reaffirmed Investment Grade Corporate Rating From DBRS, Inc.
2022-04-14 10:00 ET
Hercules Capital Announces Date for Release of First Quarter 2022 Financial Results and Conference Call
2022-03-01 11:00 ET
Hercules Capital Announces Upcoming Event for the Financial Community
2022-02-22 21:10 ET
Hercules Capital Reports Fourth Quarter and Full-Year 2021 Financial Results
2022-02-22 11:02 ET
Hercules Capital Announces New Supplemental Cash Distribution of $0.60 per Share
2022-02-22 11:00 ET
Hercules Capital Declares Cash Distribution of $0.33 per Share for the Fourth Quarter of 2021
2022-02-08 11:00 ET
Hercules Capital Announces Date for Release of Fourth Quarter and Full-Year 2021 Financial Results and Conference Call
2022-02-02 12:00 ET
Tarsus Completes Enrollment for the Pivotal Phase 3 Saturn-2 Trial of TP-03 to Treat Demodex Blepharitis and Secures $175 Million Credit Facility
2022-02-01 11:00 ET
Hercules Capital Enhances C-Suite for Future Growth
2022-01-20 15:35 ET
Hercules Capital Closes Upsized Public Offering of $350.0 Million 3.375% Notes Due 2027
2022-01-14 22:33 ET
Hercules Capital Prices Upsized Public Offering of $350.0 Million 3.375% Notes due 2027
2021-12-17 12:00 ET
NorthSea Therapeutics Completes US$80 Million Series C Fundraising to Advance Clinical Programs in Metabolic Disorders
2021-11-29 11:00 ET
Hercules Capital Surpasses $2.0 Billion in Annual Gross Debt and Equity Commitments for First Time in History
2021-11-10 11:00 ET
Hercules Capital Further Strengthens Its Capital Resources With New $100.0 Million Multi-Currency Credit Facility
2021-11-09 21:10 ET
Hercules Capital Announces Upcoming Events for the Financial Community
2021-10-28 20:10 ET
Hercules Capital Reports Third Quarter 2021 Financial Results
2021-10-26 10:03 ET
Hercules Capital Announces Supplemental Cash Distribution of $0.07 per Share for the Third Quarter of 2021
2021-10-26 10:00 ET
Hercules Capital Increases Its Quarterly Cash Distribution to $0.33 per Share for the Third Quarter of 2021
2021-10-20 10:00 ET
Hercules Capital Announces the Appointment of Ms. Pam Randhawa to Its Board of Directors
2021-10-19 11:30 ET
Locus Biosciences Secures Financing of up to $25 Million from Hercules Capital
2021-10-14 10:00 ET
Hercules Capital Announces Date for Release of Third Quarter 2021 Financial Results and Conference Call
2021-10-05 12:00 ET
Eloxx Pharmaceuticals Secures Debt Facility of Up to $30 Million from Hercules Capital
2021-09-27 12:00 ET
Corium Secures $235 Million in Debt Financing
2021-09-27 10:00 ET
Hercules Capital Delivers a New Record by Surpassing $1.5 Billion of Annual Gross Debt and Equity Commitments
2021-09-20 12:00 ET
Phathom Pharmaceuticals Secures $200 Million Term Loan Facility from Hercules Capital
2021-09-16 20:10 ET
Hercules Capital Closes Public Offering of $325.0 Million 2.625% Notes due 2026
2021-09-13 20:41 ET
Hercules Capital Prices Public Offering of $325.0 Million 2.625% Notes Due 2026
2021-08-25 12:00 ET
Better Therapeutics Secures $50 Million Debt Facility From Hercules Capital
2021-08-02 10:00 ET
Hercules Capital Reaches $1.0 Billion Milestone in Annual Debt and Equity Commitments for the Fourth Consecutive Year
2021-07-29 20:10 ET
Hercules Capital Reports Second Quarter 2021 Financial Results
2021-07-27 10:01 ET
Hercules Capital Announces Supplemental Cash Distribution of $0.07 Per Share for the Second Quarter Of 2021
2021-07-27 10:00 ET
Hercules Capital Declares Cash Distribution of $0.32 per Share for the Second Quarter of 2021
2021-07-15 10:00 ET
Hercules Capital Announces Date for Release of Second Quarter 2021 Financial Results and Conference Call
2021-06-25 17:23 ET
Hercules Capital Announces the Appointment of Wade Loo to Its Board of Directors
2021-06-08 10:00 ET
Hercules Capital Announces Date of 2021 Annual Meeting of Stockholders
2021-06-03 11:01 ET
Nabriva Agrees to Extension of Principal Debt Repayments Under Existing Loan Agreement with Hercules Capital
2021-05-28 17:05 ET
Hercules Capital Announces Its Intention to Fully Redeem its 5.25% Notes due 2025
2021-05-19 12:00 ET
HiberCell Closes $67.4 Million Series B Financing and Secures $30 Million Debt Facility from Hercules Capital
2021-05-14 12:30 ET
SCYNEXIS Secures Term Loan Facility for up to $60 Million with Hercules Capital and Silicon Valley Bank
2021-05-12 14:35 ET
Gibraltar Business Capital Announces $150MM Line of Credit with Bank of America
2021-04-29 20:10 ET
Hercules Capital Reports First Quarter 2021 Financial Results
2021-04-27 10:03 ET
Hercules Capital Announces Fiscal 2021 Supplemental Cash Distribution of $0.28 Per Share
2021-04-27 10:00 ET
Hercules Capital Declares Cash Distribution of $0.32 per Share for the First Quarter of 2021
2021-04-15 10:00 ET
Hercules Capital Announces Date for Release of First Quarter 2021 Financial Results and Conference Call
2021-03-25 10:00 ET
Hercules Adviser LLC Announces the Closing of Its Inaugural Institutional Private Credit Fund
2021-03-08 11:00 ET
Hercules Capital Receives Baa3 Investment Grade Credit and Corporate Rating from Moody’s Investors Service
2021-03-04 21:21 ET
Hercules Capital Completes Investment Grade Bond Offering of $50.0 Million of 4.55% Notes due March 2026
2021-03-02 11:00 ET
Hercules Capital Announces Upcoming Event for the Financial Community
2021-02-23 21:10 ET
Hercules Capital Reports Fourth Quarter and Full-Year 2020 Financial Results
2021-02-22 11:02 ET
Hercules Capital Announces Supplemental Cash Distribution of $0.05 per Share for the Fourth Quarter of 2020
2021-02-22 11:00 ET
Hercules Capital Declares Cash Distribution of $0.32 per Share for the Fourth Quarter of 2020
2021-02-09 11:00 ET
Hercules Capital Announces Date for Release of Fourth Quarter and Full-Year 2020 Financial Results and Conference Call
2020-11-18 15:00 ET
CloudBolt Announces $35 Million in Series B Funding Led by Insight Partners
2020-11-04 22:03 ET
Hercules Capital Announces an Investment Grade Bond Offering Totaling $100.0 Million Due 2026
2020-11-03 16:57 ET
Udacity Drives 120% Enterprise and Government Growth in Q3, Secures $75 Million to Continue Momentum
2020-10-29 20:10 ET
Hercules Capital Reports Third Quarter 2020 Financial Results
2020-10-28 20:10 ET
Hercules Capital Gains Additional Liquidity for New Investments with Approval of Third SBA License
2020-10-27 10:02 ET
Hercules Capital Announces Supplemental Cash Distribution of $0.02 per Share for the Third Quarter of 2020
2020-10-27 10:00 ET
Hercules Capital Declares Cash Distribution of $0.32 per Share for the Third Quarter of 2020
2020-10-22 10:00 ET
Hercules Capital Announces Date for Release of Third Quarter 2020 Financial Results and Conference Call
2020-10-01 20:30 ET
Geron Secures Loan Facility for Up to $75 Million
2020-08-04 20:05 ET
UNITY Biotechnology Announces $80M Debt Financing From Hercules Capital
2020-07-30 20:10 ET
Hercules Capital Reports Second Quarter 2020 Financial Results
2020-07-29 10:00 ET
Hercules Capital Surpasses $1.0 Billion in Cumulative Distributions to Shareholders since IPO
2020-07-22 20:10 ET
Hercules Capital Announces Date for Release of Second Quarter 2020 Financial Results and Conference Call
2020-06-08 10:00 ET
Hercules Capital Receives SBA “Green Light” Letter Approval to Complete Its Third SBIC License
2020-06-03 20:10 ET
Hercules Capital Completes 5-Year Investment Grade Bond Offering of $70.0 Million of 4.31% Notes due June 2025
2020-05-04 20:10 ET
Hercules Capital Reports First Quarter 2020 Financial Results
2020-05-01 10:00 ET
Hercules Capital Declares Cash Distribution of $0.32 per Share for the First Quarter of 2020
2020-04-27 10:00 ET
Hercules Capital Announces Date of 2020 Annual Meeting of Stockholders and Special Meeting of Stockholders
2020-04-16 10:00 ET
Hercules Capital Announces Date for Release of First Quarter 2020 Financial Results and Conference Call
2020-03-23 10:00 ET
Hercules Capital Business and Coronavirus Update
2020-02-20 21:10 ET
Hercules Capital Reports Fourth Quarter and Record Full-Year 2019 Financial Results
2020-02-20 11:00 ET
Hercules Capital Strengthens Its Capital Resources with New $400.0 Million Credit Facility to Support Continued Investment Portfolio Growth
2020-02-19 21:12 ET
Hercules Capital Announces Supplemental Cash Distribution of $0.08 per Share for the Fourth Quarter of 2019
2020-02-19 21:10 ET
Hercules Capital Declares Distribution of $0.32 per Share for the Fourth Quarter of 2019
2020-02-06 11:00 ET
Hercules Capital Announces 5-Year Investment Grade Bond Offering Totaling $120.0 Million
2020-01-30 11:00 ET
Hercules Capital Announces Date for Release of Fourth Quarter and Full-Year 2019 Financial Results and Conference Call
2020-01-14 11:00 ET
Hercules Capital Reaches $10.0 Billion Milestone in Total Debt Commitments Since Inception
2020-01-08 11:00 ET
Hercules Capital Highlights 2019 Achievements, Setting a New Investment Record with $1.47 Billion in Total New Debt and Equity Commitments

SEC forms

Show financial reports only

SEC form 8
2024-02-15 00:00 ET
Hercules Capital published news for 2023 q4
SEC form 8
2024-02-15 00:00 ET
Hercules Capital published news for 2023 q4
SEC form 8
2024-02-15 00:00 ET
Hercules Capital published news for 2023 q4
SEC form 10
2024-02-15 00:00 ET
Hercules Capital published news for 2023 q4
SEC form 8
2024-02-15 00:00 ET
Hercules Capital published news for 2023 q4
SEC form 8
2023-11-02 16:22 ET
Hercules Capital published news for 2023 q3
SEC form 10
2023-11-02 16:15 ET
Hercules Capital published news for 2023 q3
SEC form 10
2023-11-02 00:00 ET
Hercules Capital published news for 2023 q3
SEC form 6
2023-08-03 16:30 ET
Hercules Capital published news for 2023 q2
SEC form 10
2023-08-03 16:18 ET
Hercules Capital reported for 2023 q2
SEC form 10
2023-08-03 00:00 ET
Hercules Capital reported for 2023 q2
SEC form 8
2023-08-03 00:00 ET
Hercules Capital published news for 2023 q2
SEC form 6
2023-07-20 16:30 ET
Hercules Capital published news for 2023 q2
SEC form 6
2023-06-23 16:30 ET
Hercules Capital published news for 2023 q1
SEC form 8
2023-05-04 00:00 ET
Hercules Capital published news for 2023 q1
SEC form 10
2023-05-04 00:00 ET
Hercules Capital published news for 2023 q1
SEC form 6
2023-03-13 07:51 ET
Hercules Capital published news for 2022 q4
SEC form 6
2023-02-16 16:20 ET
Hercules Capital published news for 2022 q4
SEC form 10
2023-02-16 16:08 ET
Hercules Capital reported for 2022 q4
SEC form 10
2023-02-16 00:00 ET
Hercules Capital reported for 2022 q4
SEC form 8
2023-02-16 00:00 ET
Hercules Capital published news for 2022 q4
SEC form 6
2023-01-27 16:30 ET
Hercules Capital published news for 2022 q4
SEC form 6
2023-01-17 07:22 ET
Hercules Capital published news for 2022 q4
SEC form 6
2022-11-02 16:17 ET
Hercules Capital published news for 2022 q3
SEC form 10
2022-11-02 16:08 ET
Hercules Capital published news for 2022 q3
SEC form 8
2022-11-02 00:00 ET
Hercules Capital published news for 2022 q3
SEC form 10
2022-11-02 00:00 ET
Hercules Capital published news for 2022 q3
SEC form 6
2022-10-18 06:30 ET
Hercules Capital published news for 2022 q3
SEC form 6
2022-07-28 16:30 ET
Hercules Capital published news for 2022 q2
SEC form 10
2022-07-28 16:16 ET
Hercules Capital published news for 2022 q2
SEC form 6
2022-06-27 08:59 ET
Hercules Capital published news for 2022 q1
SEC form 6
2022-06-15 16:32 ET
Hercules Capital published news for 2022 q1
SEC form 6
2022-05-09 17:22 ET
Hercules Capital published news for 2022 q1
SEC form 6
2022-05-05 16:31 ET
Hercules Capital published news for 2022 q1
SEC form 10
2022-05-05 16:27 ET
Hercules Capital published news for 2022 q1
SEC form 6
2022-04-29 16:30 ET
Hercules Capital published news for 2022 q1
SEC form 10
2022-02-22 16:31 ET
Hercules Capital published news for 2021 q4
SEC form 6
2022-02-22 16:30 ET
Hercules Capital published news for 2021 q4
SEC form 6
2022-02-01 06:08 ET
Hercules Capital published news for 2021 q4
SEC form 6
2022-01-21 16:18 ET
Hercules Capital published news for 2021 q4
SEC form 6
2022-01-21 08:01 ET
Hercules Capital published news for 2021 q4
SEC form 6
2022-01-18 17:07 ET
Hercules Capital published news for 2021 q4
SEC form 6
2022-01-10 06:08 ET
Hercules Capital published news for 2021 q4
SEC form 6
2021-11-29 17:05 ET
Hercules Capital published news for 2021 q3
SEC form 6
2021-11-10 07:07 ET
Hercules Capital published news for 2021 q3
SEC form 6
2021-10-28 16:42 ET
Hercules Capital published news for 2021 q3
SEC form 10
2021-10-28 16:30 ET
Hercules Capital published news for 2021 q3
SEC form 6
2021-10-20 08:46 ET
Hercules Capital published news for 2021 q3
SEC form 6
2021-09-24 16:01 ET
Hercules Capital published news for 2021 q2
SEC form 6
2021-09-16 17:28 ET
Hercules Capital published news for 2021 q2
SEC form 6
2021-09-15 06:10 ET
Hercules Capital published news for 2021 q2
SEC form 6
2021-07-29 16:40 ET
Hercules Capital published news for 2021 q2
SEC form 10
2021-07-29 16:32 ET
Hercules Capital published news for 2021 q2
SEC form 6
2021-07-13 16:30 ET
Hercules Capital published news for 2021 q2
SEC form 6
2021-06-25 16:45 ET
Hercules Capital published news for 2021 q1
SEC form 6
2021-05-28 17:00 ET
Hercules Capital published news for 2021 q1
SEC form 6
2021-04-29 16:40 ET
Hercules Capital published news for 2021 q1
SEC form 10
2021-04-29 16:30 ET
Hercules Capital published news for 2021 q1
SEC form 6
2021-04-27 16:31 ET
Hercules Capital published news for 2021 q1
SEC form 6
2021-03-08 07:00 ET
Hercules Capital published news for 2020 q4
SEC form 6
2021-03-04 16:48 ET
Hercules Capital published news for 2020 q4
SEC form 6
2021-02-23 16:40 ET
Hercules Capital published news for 2020 q4
SEC form 10
2021-02-23 16:31 ET
Hercules Capital published news for 2020 q4
SEC form 6
2021-02-12 16:19 ET
Hercules Capital published news for 2020 q4
SEC form 6
2020-11-04 17:11 ET
Hercules Capital published news for 2020 q3
SEC form 6
2020-10-29 16:40 ET
Hercules Capital published news for 2020 q3
SEC form 10
2020-10-29 16:30 ET
Hercules Capital published news for 2020 q3
SEC form 6
2020-10-28 16:21 ET
Hercules Capital published news for 2020 q3